" class="no-js "lang="en-US"> Elekta Archives - Medtech Alert
Thursday, March 28, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Elekta to Appoint Tobias Hägglöv as Chief Financial Officer

Elekta (STO: EKTA-B) announced today that it will appoint Tobias Hägglöv as Chief Financial Officer […]

More Cancer Patients in Africa to Benefit from Advanced Radiation Therapy with Elekta Unity MR-Linac

Elekta (EKTA-B.ST) announced today that its latest African order for Elekta Unity MR-Linac comes less […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more